Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity
- PMID: 17150968
- DOI: 10.1074/jbc.M606728200
Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity
Abstract
The transcription factor NFkappaB plays a critical role in normal and pathophysiological immune responses. Therefore, NFkappaB and the signaling pathways that regulate its activation have become a major focus of drug development programs. Withania somnifera (WS) is a medicinal plant that is widely used in Palestine for the treatment of various inflammatory disorders. In this study we show that the leave extract of WS, as well as its major constituent withaferin A (WA), potently inhibits NFkappaB activation by preventing the tumor necrosis factor-induced activation of IkappaB kinase beta via a thioalkylation-sensitive redox mechanism, whereas other WS-derived steroidal lactones, such as withanolide A and 12-deoxywithastramonolide, are far less effective. To our knowledge, this is the first communication of IkappaB kinase beta inhibition by a plant-derived inhibitor, coinciding with MEK1/ERK-dependent Ser-181 hyperphosphorylation. This prevents IkappaB phosphorylation and degradation, which subsequently blocks NFkappaB translocation, NFkappaB/DNA binding, and gene transcription. Taken together, our results indicate that pure WA or WA-enriched WS extracts can be considered as a novel class of NFkappaB inhibitors, which hold promise as novel anti-inflammatory agents for treatment of various inflammatory disorders and/or cancer.
Similar articles
-
Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.BMC Genomics. 2010 Dec 2;11 Suppl 4(Suppl 4):S25. doi: 10.1186/1471-2164-11-S4-S25. BMC Genomics. 2010. PMID: 21143809 Free PMC article.
-
Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression.Mol Cancer Ther. 2006 Jun;5(6):1434-45. doi: 10.1158/1535-7163.MCT-06-0096. Mol Cancer Ther. 2006. PMID: 16818501
-
Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells.Phytother Res. 2007 Oct;21(10):905-13. doi: 10.1002/ptr.2180. Phytother Res. 2007. PMID: 17562568
-
Molecular insight in the multifunctional activities of Withaferin A.Biochem Pharmacol. 2012 Nov 15;84(10):1282-91. doi: 10.1016/j.bcp.2012.08.027. Epub 2012 Sep 6. Biochem Pharmacol. 2012. PMID: 22981382 Review.
-
Withaferin A: From Ancient Remedy to Potential Drug Candidate.Molecules. 2021 Dec 20;26(24):7696. doi: 10.3390/molecules26247696. Molecules. 2021. PMID: 34946778 Free PMC article. Review.
Cited by
-
Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.Mol Cancer. 2010 May 3;9:99. doi: 10.1186/1476-4598-9-99. Mol Cancer. 2010. PMID: 20438634 Free PMC article.
-
Jasmonate responsive transcription factor WsMYC2 regulates the biosynthesis of triterpenoid withanolides and phytosterol via key pathway genes in Withania somnifera (L.) Dunal.Plant Mol Biol. 2019 Jul;100(4-5):543-560. doi: 10.1007/s11103-019-00880-4. Epub 2019 May 14. Plant Mol Biol. 2019. PMID: 31090025
-
Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-κB activation.Oncotarget. 2018 Feb 7;9(18):14509-14523. doi: 10.18632/oncotarget.24429. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581860 Free PMC article.
-
Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells.Nutr Cancer. 2008;60 Suppl 1(Suppl 1):51-60. doi: 10.1080/01635580802381477. Nutr Cancer. 2008. PMID: 19003581 Free PMC article.
-
Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives.Molecules. 2021 Jun 17;26(12):3696. doi: 10.3390/molecules26123696. Molecules. 2021. PMID: 34204308 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous